The professor clearly stated that they have equity funding to finish the trial. which will not dilute shareholder value. So no, it wont be a capital raising, and he said its not debt, so I'm confused, but more importantly we have funding and that was clearly stated.
Teva were a big pile sheat, so I'm glad they are gone. They were a generic company
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$2.39 |
Change
0.110(4.82%) |
Mkt cap ! $3.059B | |||
| Open | High | Low | Value | Volume |
| $2.31 | $2.43 | $2.30 | $15.10M | 6.360M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 9186 | $2.38 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.40 | 22000 | 3 |
View Market Depth
| Last trade - 16.11pm 23/07/2025 (20 minute delay) ? |
| MSB (ASX) Chart |